Form 603 Corporations Law Section 671B Notice of initial substantial holder To: Company Name/Scheme STARPHARMA HOLDINGS LIMITED ACN/ARSN 078 532 180 1. Details of substantial holder (1) Name: UBS Group AG and its related bodies corporate ACN/ARSN...
Becoming a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Ceasing to be a substantial holder
- Change in substantial holding
- Change of Director Interest Notice - R Basser
- Change of Director Interest Notice - R Thomas
- Change of Director Interest Notice - L Cheng
Later from Starpharma
- Preliminary Final Report
- 2026 Annual Report
- 2026 Appendix 4G and Corporate Governance Statement
- FY26 Key Financial Results and Annual Report
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma